Radaideh AbdelRahman, El-Khateeb Mohammed, Batieha Anwar M, Nasser Abeer S, Ajlouni Kamel M
National Center for Diabetes Endocrinology and Genetics Jordan University, Amman, Jordan.
Saudi Med J. 2003 Apr;24(4):352-5.
An association between diabetes mellitus and autoimmune thyroid disease is well known. We have investigated the prevalence of thyroid dysfunction and autoimmunity in type 1 diabetic patients.
Seventy-nine type 1 diabetic patients were recruited in the study, and underwent complete investigations for thyroid function, which included free thyroxine, free tri-iodothyronine, and thyroid stimulating hormone, of those only 64 patients had performed thyroid autoantibodies (TAb); anti- thyroid peroxidase antibodies (TPOAb) or antimicrosomal antibodies and thyroglobulin antibodies (TgAb). They were compared with 127 healthy subjects matched for sex and age. This study was carried out at the National Center for Diabetes, Endocrinology and Genetics, Jordan University, Amman, Jordan between 2000 and 2001.
In the diabetic group, 7 cases (8.9%) of thyroid dysfunction were detected, 4 of these were diagnosed as subclinical hypothyroidism, whereas the other 3 had overt hypothyroidism and were on thyroxine replacement therapy. In the control group, 6 (4.7%) subjects were diagnosed as subclinical hyperthyroidism. There was a significant difference in thyroid function variables between diabetics and controls. Among type 1 diabetic patients, 7 (9.2%) had thyroid autoantibodies, 5 with positive TPOAb only and 2 with positive TAb; TPOAb or antimicrosomal antibodies and TgAb; compared with 8 (6.3%) in the control group, 4 with positive TPOAb only and 4 with positive TAb; TPOAb or antimicrosomal antibodies and TgAb P=0.68.
Biochemical thyroid dysfunction and thyroid autoimmunity were evident in type 1 diabetics who were apparently euthyroid, with no significant difference between diabetics and controls.
糖尿病与自身免疫性甲状腺疾病之间的关联已广为人知。我们调查了1型糖尿病患者甲状腺功能障碍和自身免疫的患病率。
本研究招募了79名1型糖尿病患者,对其进行了甲状腺功能的全面检查,包括游离甲状腺素、游离三碘甲状腺原氨酸和促甲状腺激素,其中只有64名患者检测了甲状腺自身抗体(TAb);抗甲状腺过氧化物酶抗体(TPOAb)或抗微粒体抗体以及甲状腺球蛋白抗体(TgAb)。将他们与127名年龄和性别匹配的健康受试者进行比较。本研究于2000年至2001年在约旦安曼约旦大学国家糖尿病、内分泌学和遗传学中心进行。
在糖尿病组中,检测到7例(8.9%)甲状腺功能障碍,其中4例被诊断为亚临床甲状腺功能减退,而另外3例为明显的甲状腺功能减退并接受甲状腺素替代治疗。在对照组中,6名(4.7%)受试者被诊断为亚临床甲状腺功能亢进。糖尿病患者和对照组之间的甲状腺功能变量存在显著差异。在1型糖尿病患者中,7例(9.2%)有甲状腺自身抗体,5例仅TPOAb阳性,2例TAb阳性;TPOAb或抗微粒体抗体以及TgAb阳性;对照组中有8例(6.3%),4例仅TPOAb阳性,4例TAb阳性;TPOAb或抗微粒体抗体以及TgAb阳性,P = 0.68。
在看似甲状腺功能正常的1型糖尿病患者中,生化甲状腺功能障碍和甲状腺自身免疫明显,糖尿病患者和对照组之间无显著差异。